The December 2, 2020 vote came after the CND—which comprises 53 states—took on board World Health Organization recommendations made two years ago regarding cannabis and its derivatives. These recommendations, which recognized the potential therapeutic effects of marijuana were that:
- Whole-plant marijuana and cannabis resin should be removed from Schedule IV, but kept in Schedule I.
- Delta-9-tetrahydrocannabinol (THC) and its isomers should be completely removed from a separate 1971 drug treaty and instead added to Schedule I of the 1961 convention.
- Cannabidiol and CBD-focused preparations containing no more than 0.2 percent THC should not be "under international control" at all.
The fact that the CND is acting on and formalising WHO recommendation couldn’t be bigger in terms of endorsements for the comparative safety of cannabis, but the drug is still staying in the “dangerous” category, just ranking slightly lower in terms of the harm it can cause. Impossible as it sounds, until now marijuana was actually rated as more dangerous than morphine and fentanyl.
After the vote, some countries made statements. The US voted to remove cannabis from Schedule IV, while retaining in Schedule I, stating that this move was “consistent with the science demonstrating that while a safe and effective cannabis-derived therapeutic has been developed, cannabis itself continues to pose significant risks to public health and should continue to be controlled under the international drug control conventions”.